Related content

Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients

By Mauri M.C.   Volonteri L.S.   Fiorentini A.   Invernizzi G.   Nerini T.   Baldi M.   Bareggi S.R.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 197-198

Elsevier

Access to resources Recommend Favorite

GABA and Homovanillic Acid in the Plasma of Schizophrenic and Bipolar I Patients

By Arrúe Aurora   Dávila Ricardo   Zumárraga Mercedes   Basterreche Nieves   González-Torres Miguel   Goienetxea Biotza   Zamalloa Maria   Anguiano Juan   Guimón José  

Neurochemical Research, Vol. 35, Iss. 2, 2010-02 ,pp. : 247-253

Springer Publishing Company

Access to resources Recommend Favorite

Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls

By Tsai Meng-Chang   Chang Chia-Ming   Liu Chia-Yih   Chang Pi-Yueh   Huang Tiao-Lai  

International Journal of Psychiatry in Clinical Practice, Vol. 15, Iss. 2, 2011-06 ,pp. : 106-111

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis

By Michel T. M.   Thome J.   Martin D.   Nara K.   Zwerina S.   Tatschner T.   Weijers H. G.   Koutsilieri E.  

Journal of Neural Transmission, Vol. 111, Iss. 9, 2004-09 ,pp. : 1191-1201

Springer Publishing Company

Access to resources Recommend Favorite

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

By Ranjekar P.K.   Hinge A.   Hegde M.V.   Ghate M.   Kale A.   Sitasawad S.   Wagh U.V.   Debsikdar V.B.   Mahadik S.P.  

Psychiatry Research, Vol. 121, Iss. 2, 2003-12 ,pp. : 109-122

Elsevier

Access to resources Recommend Favorite